Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CP | UNP |
|---|---|---|
| Price | $87.62 | $272.63 |
| Change today | ▼ 0.75% | ▼ 1.05% |
| Market cap | $77.02B | $161.96B |
| Return, 3 months | +3.8% | +5.4% |
| Return, year to date | +20.0% | +19.6% |
| Return, 1 year | +20.4% | +20.8% |
| P/E (TTM) | 28.7 | 22.1 |
| P/B | 2.3 | 7.8 |
| P/E percentile vs own 5y | 80th | 86th |
| Dividend yield | 0.77% | 2.02% |
| Revenue growth (YoY, latest qtr) | +12.6% | +11.5% |
| Net profit growth (YoY) | -17.0% | +6.2% |
| Gross margin | 36.8% | 45.6% |
| Operating margin | 36.8% | 40.0% |
| Net margin | 25.0% | 28.8% |
| Return on equity | 8.3% | 39.7% |
| Analyst target vs. price | +17.2% | +22.6% |
| Analyst buy share | 76% | 79% |
| RSI (14) | 44 | 35 |
| 30-day volatility | 20.7% | 20.4% |
| Max drawdown, 1 year | -12.9% | -12.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.